To study mechanism underlying an increase in serum level of FABP4 in patients with acute myocardial infarction

To study mechanism underlying an increase in serum level of FABP4 in patients with acute myocardial infarction - acute myocardial infarction and serum FABP4

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015292

Enrollment

Registered

2014-10-01

Start date

2014-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myocardial infarction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with acute myocardial infarction, onset of which is within 8 hours Patients taking percutaneous coronary intervention

Exclusion criteria

Exclusion criteria: Patients requiring intra-aortic baloon pumping or percutaneous cardiopulmonary support due to cardiac shock Patients with uncontrolable arrythmia Patients with severe liver dysfunction Patients with severe renal dysfunction

Design outcomes

Primary

Measure	Time frame
To estimate what part of blood samples shows the highest level of serum FABP4 around the heart.	—

Countries

Japan

Contacts

Public ContactTatsuya Iso

Gunma University Graduate School of Medicine Education and Research Support Center

isot@gunma-u.ac.jp027-220-8145

Outcome results